The history of Sildenafil presents a intricate picture for investors. While the initial release generated massive returns, the expiration of its patent opened the avenue to off-brand competitors, dramatically reducing https://bookmarkinglive.com/story22713887/sildenafil-and-big-pharma-a-volatile-opportunity